Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis (StopRA)
Sponsor: Autoimmunity Centers of Excellence
Terminated
Enrollment was closed before reaching the target. In the 1st interim analysis after enrollment closure, the follow up \& treatment of active participants were stopped early due to evidence of futility.
Other terminated trials from Autoimmunity Centers of Excellence
- Juvenile Dermatomyositis (JDM) · Phase PHASE2 · Mar 2024
- IgG4 Related Disease · Phase PHASE2 · Jan 2024
- Pemphigus Foliaceus · Phase PHASE1 · Jan 2023
- SLE · Phase PHASE2 · Jul 2019
- Lupus Erythematosus, Cutaneous · Phase PHASE1 · Oct 2018
See all terminations from Autoimmunity Centers of Excellence
Other Healthy Participants trials with similar outcome
A PHASE2 clinical study on Healthy Participants and Rheumatoid Arthritis (RA) Prevention, this trial is terminated or withdrawn. The trial is conducted by Autoimmunity Centers of Excellence and has accumulated 34 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
34 versions recorded-
Jul 2025 — Present [monthly]
Terminated PHASE2
-
Sep 2024 — Jul 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2024 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2023 — Jan 2024 [monthly]
Terminated PHASE2
Status: Completed → Terminated
▶ Show 29 earlier versions
-
Aug 2023 — Dec 2023 [monthly]
Completed PHASE2
-
May 2023 — Aug 2023 [monthly]
Completed PHASE2
-
Jan 2023 — May 2023 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Sep 2022 — Jan 2023 [monthly]
Active Not Recruiting PHASE2
-
Jun 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE2
-
Dec 2021 — Jun 2022 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jun 2021 — Dec 2021 [monthly]
Recruiting PHASE2
-
Apr 2021 — Jun 2021 [monthly]
Recruiting PHASE2
-
Feb 2021 — Apr 2021 [monthly]
Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE2
-
May 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Mar 2020 — May 2020 [monthly]
Recruiting PHASE2
-
Jan 2020 — Mar 2020 [monthly]
Recruiting PHASE2
-
Nov 2019 — Jan 2020 [monthly]
Recruiting PHASE2
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE2
-
Aug 2019 — Oct 2019 [monthly]
Recruiting PHASE2
-
Jun 2019 — Aug 2019 [monthly]
Recruiting PHASE2
-
May 2019 — Jun 2019 [monthly]
Recruiting PHASE2
-
Apr 2019 — May 2019 [monthly]
Recruiting PHASE2
-
Jan 2019 — Apr 2019 [monthly]
Recruiting PHASE2
-
Dec 2018 — Jan 2019 [monthly]
Recruiting PHASE2
-
Oct 2018 — Dec 2018 [monthly]
Recruiting PHASE2
-
Sep 2018 — Oct 2018 [monthly]
Recruiting PHASE2
-
Aug 2018 — Sep 2018 [monthly]
Recruiting PHASE2
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE2
-
Aug 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Feb 2017 — Aug 2017 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Autoimmunity Centers of Excellence
- National Institute of Allergy and Infectious Diseases (NIAID)
For direct contact, visit the study record on ClinicalTrials.gov .